Thank you!
We will contact you shortly.
About Cubed
We provide a wide range of services to meet even the most daring requirements.
Psychedelic substances like psilocybin (found in magic mushrooms), MDMA (often known as ecstasy), and ketamine are undergoing clinical trials to establish their efficacy and safety for therapeutic use. If these trials continue to show positive results, leading to broader legalization and acceptance, the number of users could potentially grow into the millions globally. This growth will be influenced by factors such as regulatory approvals, the establishment of treatment protocols, insurance coverage, and the cultural shift towards accepting these substances as legitimate medicine.
Trainee program for young talents with big ambitions
Relocation and full support for experts from cities
100+ experts who work in different industry fields
Strategy
The excellence of our services has been proved by the following awards.
R&D Leader in
TechQuantum is rated in the Leadership across four major industries such as Aerospace, Automotive, Telecom, and Industrial. We are proud to be a top engineering services and products provider across the globe striving to use technology to its fullest potential.
Best Service
ProviderWe have deserved to be named one of the best web design companies in the US. Their annual research evaluates each company’s depth of focus in their area of expertise, as well as the company’s proven ability to deliver results for their clients.
Innovation
LeaderOur company is glad to be recognized as Innovations Leader staying at the forefront of innovation. We play the main role in helping business owners and large organizations to drive their business, increase profits, and stand out from the crowd.
Communicator
AwardWe are honored to receive a Communicator Award for the Legal Media website. This is the leading and one of a kind in the world awards program which recognizes great and perspective ideas in marketing and communications.
Use of Proceeds
Based on the maximum amount of $10,000,000
30%
Working Capital
Lab Operations
20%
Phase 2 Buildout
Drug Establishment License
20%
Pre-clinical Development
30%
Drug Development
Clinical Development
"We are in the middle of a modern industrial revolution.
The world economy is strong and promises to remain so at least for the foreseeable future. In the coming years, advances in AI, IoT, electric vehicles and autonomous driving systems will likely revolutionize business models in many industries, and the energy generated by that should have a positive impact on the world economy."
Takehiko Kakiuchi
Mitsubishi Corporation President & Chief Executive Officer
January 2018
Pricing
Offering Type
Regulation A+For all periodSecurity Type
Common SharesmonthlyMaximum Offering
$10millionTarget Offering
$5millionMinimum Investment
$500Available Shares
10millionValuation
$50millionBroker Dealer
DalmoreGroupTransfer Agent
Odyssey
Milestones
Dealers License
When we’re done with the idea, we move towards to prototyping. At this step, we implement all your instructions and requirements to the product prototype. You’ll see in detail how everything will look like when the product is released.
First Molecules
We understand that every business is unique, and so are its needs. The discovery stage is where your needs and requirements are articulated. Then our professional team begins the research process, deep site analysis.
Natural Psilocybin
We begin the design process with well-thought-out strategic planning. Our specialist will define your specific business objectives, organize the content so that to meet the needs of your potential clients, visitors, or buyers.
Clinic Supply Agreements
This is the final stage of the website design process. Once you are satisfied with the approved design, we start testing it for possible bugs. We check your website on its features, test it internally and on various devices and browsers to make sure nothing’s been missed.
Drug Establishment License
Our expert designers work with you to get the right picture of your new website and to consider all the wishes and requirements. This process includes diverse approvals, tests, reviews, and close communication.
About The Company
The profound expertise of our team, deep understanding of all business aspects, ideal knowledge of processes will help to deal with various issues.
We create unique and innovative solutions for our customers along with the high-quality support services and personal approach to any case. Feel free to entrust your business to our experts, and you’ll see the difference!
Follow us:
Drug Development
Creative Designs Inc.
Self-Employed
JUE Marketing Agency
Illustrator and Graphic Designer
Freelance Illustrator
Graphic Designer Intern
Jan 2022 - PresentNew York, NY
Jan 2019 - Jan 2022New York, NY
Sep 2018 - Jan 2019New York, NY
Every day, I work with exciting projects that challenge my artistic abilities and push me to explore new techniques. One of the best aspects of my work here is the collaboration with a team of talented individuals.
From illustrating for children's books and editorial publications to creating visual assets for marketing campaigns and brand identities, each project presented a unique set of challenges and creative possibilities.
Here, I gained invaluable experience and developed a strong foundation in the field of graphic design. One of my responsibilities was to assist the senior graphic designers in creating marketing materials for clients.
Why Choose Us
Experience
We have extensive experience and can be proud of 10 000+ completed projects.
Support
We value each client and always respond to feedback throughout our cooperation.
Technologies
We create our products using the latest technologies to ensure the best experience.
Stock Price is going up in
Get Pro Plan at the Price of Standard
Deal Expires: December 31, 2024
CUBEDBIOTECH
Products and services of the highest quality
Want to invest in Cubed?
Send a request and get a complete list of our offers!
FAQ
What is your share price?
$1.00 USD
What is the minimum investment amount?
$500 USD
What kind of shares are you issuing?
Common Stock
How much are you raising?
Up to $10 million USD
What is your current valuation?
Pre-money valuation is approximately $50 million USD
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Will the company be on the NASDAQ?
If we meet our fundraising goals, the company intends to apply for a direct listing on NASDAQ and will reserve the symbol “PSIL” *
Forward-looking Statements Disclaimer
The offering materials and this letter may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These forward-looking statements are based on the beliefs of, assumptions made by, and information currently available to the company’s management. When used in the offering materials, the words “estimate,” “project,” “believe,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements, which constitute forward looking statements. These statements reflect management’s current views with respect to future events and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.